export interface Clinician {
  id: number;
  name: string;
  credentials: string;
  title: string;
  specialty: string;
  type: string;
  photo: string;
  bio: string;
  hasVideo: boolean;
  hasSession: boolean;
  sessionLabel: string;
  appointmentUrl: string;
  videoUrl?: string;
  appointmentLabel?: string;
}

export interface SupportStaff {
  id: number;
  name: string;
  credentials: string;
  role: string;
  note?: string;
}

export interface Trial {
  id: string;
  title: string;
  status: string;
  description: string;
  phase: string;
}

export interface Session {
  id: number;
  month: string;
  day: string;
  dayOfWeek: string;
  time: string;
  title: string;
  presenter: string;
  description: string;
  status: 'upcoming' | 'completed' | 'cancelled';
}

const CITY_OF_HOPE_URL = 'https://www.cityofhope.org/';

export const clinicians: Clinician[] = [
  {
    id: 1,
    name: 'Dr. Michael Rosenzweig',
    credentials: 'MD',
    title: 'Chief, Division of Multiple Myeloma · Director, COH Amyloidosis Program',
    specialty: 'Hematology & Oncology · Multiple Myeloma · Amyloidosis Program Director',
    type: 'Medical Doctor',
    photo: 'https://cdn.cityofhope.org/media/bios/96842f25-1673-4f19-afc8-38c46b9d9560/default/rosenzweig-michael.jpg',
    bio: 'Dr. Michael Rosenzweig is Chief of the Division of Multiple Myeloma and Director of the Amyloidosis Program at City of Hope. A hematologist-oncologist with expertise in plasma cell disorders, he cares for patients with multiple myeloma, Waldenström macroglobulinemia, POEMS syndrome, and all forms of amyloidosis — AL, TTR, AA, and LECT2. He trained at Boston Medical Center and Memorial Sloan Kettering, and previously directed the Amyloid Treatment and Research Program at Boston University.',
    hasVideo: false,
    hasSession: true,
    sessionLabel: 'Register: Second-line options for relapsed/refractory disease — the COH experience with venetoclax for AL amyloidosis',
    appointmentUrl: 'https://www.cityofhope.org/patients/find-a-doctor/michael-rosenzweig',
    appointmentLabel: 'Schedule with Dr. Rosenzweig',
  },
  {
    id: 2,
    name: 'Dr. Lisa Lee',
    credentials: 'MD',
    title: 'Associate Clinical Professor, Hematology & Hematopoietic Cell Transplantation',
    specialty: 'Hematology & Oncology · Multiple Myeloma · Precision Medicine',
    type: 'Medical Doctor',
    photo: 'https://cdn.cityofhope.org/media/bios/0197c300-3d40-7313-b2ec-5995c543f3b7/default/lee-lisa.jpg',
    bio: 'Dr. Lisa Lee is a hematologist and Associate Clinical Professor at City of Hope Orange County (Irvine), specialising in multiple myeloma, amyloidosis, smoldering myeloma, and CAR T-cell therapy. She trained at Tufts Medical Center and was previously on faculty at UC Irvine, where she received the Amyloidosis Foundation Young Investigator\'s Award. She is the principal investigator of the SAVE trial — a study working toward earlier diagnosis of AL amyloidosis.',
    hasVideo: false,
    hasSession: true,
    sessionLabel: 'Register: SAVE trial — towards earlier diagnosis of AL amyloidosis',
    appointmentUrl: 'https://www.cityofhope.org/patients/find-a-doctor/lisa-lee',
    appointmentLabel: 'Schedule with Dr. Lisa Lee',
  },
  {
    id: 3,
    name: 'Dr. Sarah Lee',
    credentials: 'MD',
    title: 'Assistant Clinical Professor, Division of Multiple Myeloma · Hematology & HCT',
    specialty: 'Hematology & Oncology · Plasma Cell Disorders · Multiple Myeloma',
    type: 'Medical Doctor',
    photo: 'https://cdn.cityofhope.org/media/bios/b72e060e-711e-48f1-b5f9-db05221ef639/default/lee-sarah.jpg',
    bio: 'Dr. Sarah S. Lee is a hematologist-oncologist specialising in plasma cell disorders including multiple myeloma and amyloidosis. She joined City of Hope in 2023 after faculty appointments at Fred Hutchinson Cancer Research Center and Cleveland Clinic, where she was chief quality improvement fellow. By the time she arrived at City of Hope, she had co-authored 12 peer-reviewed publications and was principal investigator on seven active clinical trials.',
    hasVideo: false,
    hasSession: true,
    sessionLabel: 'Register: Second-line treatment options — the COH experience with bispecific antibodies for AL amyloidosis',
    appointmentUrl: 'https://www.cityofhope.org/patients/find-a-doctor/sarah-lee',
    appointmentLabel: 'Schedule with Dr. Sarah Lee',
  },
  {
    id: 4,
    name: 'Dr. Faizi Jamal',
    credentials: 'MD',
    title: 'Chief, Division of Cardiology · Co-Director, Amyloidosis Program · Director, Echocardiography Laboratory',
    specialty: 'Cardiology · Cardiac Amyloidosis · Heart Failure · Cardiac Imaging',
    type: 'Medical Doctor',
    photo: 'https://cdn.cityofhope.org/media/bios/30513842-8963-49eb-a578-1b77dc885b54/default/jamal-faizi.jpg',
    bio: 'Dr. Faizi Jamal is a cardiologist and Chief of the Division of Cardiology at City of Hope, where he also directs the Echocardiography Laboratory. He specialises in cardio-oncology, cardiac imaging, heart failure, and cardiac amyloidosis, and is board-certified in cardiovascular disease, echocardiography, and nuclear cardiology. He trained at Cedars-Sinai and previously held faculty at Northwestern University Feinberg School of Medicine.',
    hasVideo: false,
    hasSession: true,
    sessionLabel: 'Register: Diagnosis of Cardiac Amyloidosis',
    appointmentUrl: 'https://www.cityofhope.org/patients/find-a-doctor/faizi-jamal',
    appointmentLabel: 'Schedule with Dr. Jamal',
  },
  {
    id: 5,
    name: 'Dr. Tibor Kovacsovics',
    credentials: 'MD',
    title: 'Chief of Hematology · Medical Director of Leukemia, COH Phoenix',
    specialty: 'Hematology & Oncology · Acute Leukemia · Stem Cell Transplantation',
    type: 'Medical Doctor',
    photo: 'https://cdn.cityofhope.org/media/bios/85764fed-a462-4167-9984-c30499b3c790/default/kovacsovics-tibor.jpg',
    bio: 'Dr. Tibor Kovacsovics is Chief of Hematology and Medical Director of Leukemia at City of Hope Cancer Center Phoenix. A hematologist-oncologist with 20 years of clinical research experience, he specialises in AML, ALL, stem cell transplantation, and amyloidosis. He trained at Harvard Medical School/MGH/Brigham and Women\'s, co-founded the Utah Amyloidosis Program at Huntsman Cancer Institute, and has served as principal investigator on dozens of landmark hematology studies.',
    hasVideo: false,
    hasSession: true,
    sessionLabel: 'Register: The role of upfront autologous SCT for primary AL amyloidosis',
    appointmentUrl: 'https://www.cityofhope.org/patients/find-a-doctor/tibor-kovacsovics',
    appointmentLabel: 'Schedule with Dr. Kovacsovics',
  },
];

export const supportStaff: SupportStaff[] = [
  {
    id: 1,
    name: 'Eve Celestial',
    credentials: 'RN',
    role: 'Multi-disciplinary Amyloid Clinic Registered Nurse',
  },
  {
    id: 2,
    name: 'Tricia Walker',
    credentials: 'NP',
    role: 'Amyloidosis Nurse Practitioner',
    note: 'Expertise in Smoldering Multiple Myeloma, Relapsed/Refractory Multiple Myeloma, Myeloproliferative Neoplasms, and Febrile Neutropenia.',
  },
  {
    id: 3,
    name: 'Justine Buchholz',
    credentials: 'NP',
    role: 'Amyloidosis Nurse Practitioner',
    note: 'Family nurse practitioner in advanced practice nursing with a certification in family care.',
  },
  {
    id: 4,
    name: 'Edelyn Whip',
    credentials: '',
    role: 'Nurse Navigator, Amyloid Clinic',
  },
  {
    id: 5,
    name: 'Gloria Higuera',
    credentials: '',
    role: 'Senior Site Liaison for Patient Scheduling',
  },
  {
    id: 6,
    name: 'Stephanie Goral',
    credentials: 'RN',
    role: 'Clinical Research Nurse for Amyloid Trials',
  },
  {
    id: 7,
    name: 'James Sanchez',
    credentials: 'PhD',
    role: 'Staff Scientist, Clinical & Translational Research',
    note: 'Leading research initiatives in healthcare delivery through scientific project development within City of Hope.',
  },
];

export const trials: Trial[] = [
  {
    id: 'NCT06097832',
    title: 'Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis (NEXICART-2)',
    status: 'Recruiting',
    description: 'Open-label Phase 1b dose escalation/expansion study of NXC-201 CAR-T cell therapy in patients with relapsed or refractory light chain (AL) amyloidosis. City of Hope (Duarte) is an active enrolling site.',
    phase: 'Phase 1b',
  },
  {
    id: 'NCT06292780',
    title: 'Linvoseltamab in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (LINKER-AL2)',
    status: 'Recruiting',
    description: 'Phase 1/2 study of linvoseltamab (an anti-BCMA bispecific antibody by Regeneron) in adults with AL amyloidosis that has returned or failed prior therapies. City of Hope (Duarte) is actively enrolling.',
    phase: 'Phase 1/2',
  },
  {
    id: 'NCT06022939',
    title: 'Dara-VCD Chemotherapy ± Stem Cell Transplant for Newly Diagnosed AL Amyloidosis',
    status: 'Recruiting',
    description: 'Phase 3 randomized trial (SWOG Cancer Research Network) comparing daratumumab + cyclophosphamide + bortezomib + dexamethasone (Dara-VCD) with or without autologous stem cell transplantation in newly diagnosed AL amyloidosis.',
    phase: 'Phase 3',
  },
  {
    id: 'NCT05652335',
    title: 'Study of JNJ-79635322 in Relapsed/Refractory Multiple Myeloma or Previously Treated AL Amyloidosis',
    status: 'Recruiting',
    description: 'Phase 1 first-in-human dose escalation study of JNJ-79635322, a novel trispecific antibody (Janssen), in participants with relapsed or refractory multiple myeloma or previously treated amyloid light-chain (AL) amyloidosis. City of Hope (Duarte) is an active site.',
    phase: 'Phase 1',
  },
];

export const sessions: Session[] = [
  {
    id: 1,
    month: 'JUL',
    day: '1',
    dayOfWeek: 'Wed',
    time: 'Time TBD',
    title: 'Second-line options for relapsed/refractory disease: the COH experience with venetoclax for AL amyloidosis',
    presenter: 'Dr. Michael Rosenzweig',
    description: 'Dr. Rosenzweig will discuss his approach to second-line treatment of AL amyloidosis and specifically the City of Hope experience with venetoclax.',
    status: 'upcoming',
  },
  {
    id: 2,
    month: 'JUL',
    day: '8',
    dayOfWeek: 'Wed',
    time: 'Time TBD',
    title: 'SAVE trial: towards earlier diagnosis of AL amyloidosis',
    presenter: 'Dr. Lisa Lee',
    description: 'Dr. Lisa Lee will review the SAVE trial and how results could possibly lead to an earlier diagnosis of AL amyloidosis.',
    status: 'upcoming',
  },
  {
    id: 3,
    month: 'JUL',
    day: '15',
    dayOfWeek: 'Wed',
    time: 'Time TBD',
    title: 'Second-line treatment options: the COH experience with bispecific antibodies for AL amyloidosis',
    presenter: 'Dr. Sarah Lee',
    description: 'Dr. Sarah Lee will discuss her approach to second-line treatment of AL amyloidosis and specifically the City of Hope experience with bispecific antibodies.',
    status: 'upcoming',
  },
  {
    id: 4,
    month: 'JUL',
    day: '22',
    dayOfWeek: 'Wed',
    time: 'Time TBD',
    title: 'Diagnosis of Cardiac Amyloidosis',
    presenter: 'Dr. Faizi Jamal',
    description: 'Dr. Jamal will review the diagnostic features of cardiac amyloidosis, red flags that clinicians examine, and the steps followed to confirm disease. Within this diagnostic process, he will discuss the emergence of novel AI tools that may increase disease detection.',
    status: 'upcoming',
  },
  {
    id: 5,
    month: 'JUL',
    day: '29',
    dayOfWeek: 'Wed',
    time: 'Time TBD',
    title: 'The role of upfront autologous SCT for primary AL amyloidosis',
    presenter: 'Dr. Tibor Kovacsovics',
    description: 'Dr. Kovacsovics will discuss autologous SCT for the treatment of AL amyloidosis: past, present, and future, including how first-line treatment has evolved and where upfront AutoSCT is considered.',
    status: 'upcoming',
  },
];
